Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Clinical trial

Sodiumhexametaphosphate Versus MTA as Pulp Capping Material for Primary Teeth ( Randomized Clinical Trial)

ID
Name
1290
Description
Sodiumhexametaphosphate will be tested as pulp capping material in comparison to MTA for primary teeth pulp therapy
Trial arms
Trial start
2023-12-20
Estimated PCD
2024-12-20
Trial end
2025-01-20
Status
Not yet recruiting
Treatment
Pulp therapy
Pulp capping material
Arms:
MTA, Sodiumhexametaphosphate
Sodiumhexametaphosphate
Sodiumhexametaphosphate
Arms:
Sodiumhexametaphosphate
MTA
MTA
Arms:
MTA
Size
100
Primary endpoint
Clinical success
One year
Radiographic success
One year
Eligibility criteria
Inclusion Criteria: * physical healthy children * cooperative children * primary molar with deep carious lesion * absence of pain or transient momentary pain Exclusion Criteria: * Uncooperative children * children with systemic disorders * periapical lesions * sever pain
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['NA'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'DOUBLE', 'whoMasked': ['PARTICIPANT', 'OUTCOMES_ASSESSOR']}}, 'enrollmentInfo': {'count': 100, 'type': 'ESTIMATED'}}
Updated at
2023-12-14

1 organization

1 product

2 indications

Organization
Minia University
Product
Sodiumhexametaphosphate
Indication
Pulp Disease
Indication
Toothache